The Venture Codex Logo

The Venture Codex

Overview

Investment fund focused on Israeli biotech companies developing drugs.

Deals · 12mo

1

Links

Stage focus

Series B
Series C

Geographic focus

Israel
United States

Sector focus

Biotechnology
Financial Services
Medical

Investment portfolio

9rounds
NAMEDATESIZE
Ukko
Jan 2026Led
$45 MSeries C
Vensica Medical
Oct 2024Led
$11 MOther Equity
Vensica Medical
Feb 2022Led
$19 MOther Equity
BioSight
Dec 2020Led
$27 MSeries C
Ayala Pharmaceuticals
May 2019Participated
$30 MSeries B
Biond Biologics
Jan 2019Led
$17 MSeries B
Gamida Cell
Jun 2017Participated
$40 MOther Equity
Pharma Two B
Feb 2017Led
$30 MOther Equity
Vidac Pharma
Jun 2016Led
$9 MSeries A
Ukko
Jan 2026Led
$45 MSeries C
Vensica Medical
Oct 2024Led
$11 MOther Equity
Vensica Medical
Feb 2022Led
$19 MOther Equity
BioSight
Dec 2020Led
$27 MSeries C
Ayala Pharmaceuticals
May 2019Participated
$30 MSeries B
Biond Biologics
Jan 2019Led
$17 MSeries B
Gamida Cell
Jun 2017Participated
$40 MOther Equity
Pharma Two B
Feb 2017Led
$30 MOther Equity
Vidac Pharma
Jun 2016Led
$9 MSeries A
9
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Israel Biotech Fund: 9 funding rounds are recorded in the selected participation categories.All available history.
Israel Biotech Fund: 9 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series A10
Series B11
Series C+20
Other Equity31

Monthly Deal Activity

Israel Biotech Fund: 9 deals are recorded across 125 months.All available history.
Israel Biotech Fund: 9 deals are recorded across 125 months. All available history
MonthDeals
Jun '161
Jul '160
Aug '160
Sep '160
Oct '160
Nov '160
Dec '160
Jan '170
Feb '171
Mar '170
Apr '170
May '170
Jun '171
Jul '170
Aug '170
Sep '170
Oct '170
Nov '170
Dec '170
Jan '180
Feb '180
Mar '180
Apr '180
May '180
Jun '180
Jul '180
Aug '180
Sep '180
Oct '180
Nov '180
Dec '180
Jan '191
Feb '190
Mar '190
Apr '190
May '191
Jun '190
Jul '190
Aug '190
Sep '190
Oct '190
Nov '190
Dec '190
Jan '200
Feb '200
Mar '200
Apr '200
May '200
Jun '200
Jul '200
Aug '200
Sep '200
Oct '200
Nov '200
Dec '201
Jan '210
Feb '210
Mar '210
Apr '210
May '210
Jun '210
Jul '210
Aug '210
Sep '210
Oct '210
Nov '210
Dec '210
Jan '220
Feb '221
Mar '220
Apr '220
May '220
Jun '220
Jul '220
Aug '220
Sep '220
Oct '220
Nov '220
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '241
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '261
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Israel Biotech Fund: Health & Life Sciences is the largest displayed sector by deal count (9 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Israel Biotech Fund: Health & Life Sciences is the largest displayed sector by deal count (9 deals). All available history
SectorDeals
Health & Life Sciences9

Deal Size Distribution

Israel Biotech Fund: 9 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Israel Biotech Fund: 9 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M1
$10M-$25M3
$25M-$50M5
$50M-$100M0
$100M-$250M0
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Israel Biotech Fund: Israel has the largest recorded deal count among the displayed regions (7 deals).All available history.

Top 2 of 2 regions; European countries are grouped as Europe.

Israel Biotech Fund: Israel has the largest recorded deal count among the displayed regions (7 deals). All available history
RegionDeals
Israel7
United States2
Israel Biotech Fund: 20 co-investors are shown, with aMoon sharing 2 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Investment Strategy

Israel Biotech Fund: Led accounts for 78% and participating for 22% of round participation.All available history.
Israel Biotech Fund: Led accounts for 78% and participating for 22% of round participation. All available history
CategoryDeals (count)Share (%)
Led778%
Participating222%
Israel Biotech Fund: Single-lead accounts for 86% and co-led for 14% of lead dynamics.All available history.
Israel Biotech Fund: Single-lead accounts for 86% and co-led for 14% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead686%
Co-led114%

Team

Benjamin Maisano

Fund Advisor and Investor

David Sidransky

Co-Founder and General Partner

Ido Zairi

General Partner

Jeffrey B. Kindler

Fund Advisor

Jonathan Fassberg

Fund Advisor

Yuval Cabilly

Co-Founder and General Partner